- Home
- / Stuart Therapeutics
Stuart Therapeutics
Total Funding
$11 M
Stuart Therapeutics Summary
Company Summary
- Overview
- Stuart Therapeutics is a biotechnology company that develops a tissue reparative platform for eye diseases. It offers PolyCol, a polypeptide sequence that is designed to repair damaged extracellular matrix (ECM) helical collagen.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Stuart, FL, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Diane Black, Chairman of Audit Committee
Eric Schlumpf, President, CEO, Director
Walter Flamenbaum, Chairman of Compensation Comittee
Operating MetricsView all
Expertise Areas
3
May, 2023
LocationsView all
1 location detected
Stuart, FL HQ
United States
411 SE Osceola St #203